136 related articles for article (PubMed ID: 28265829)
1. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus.
Poneros JM; Faye AS; Barr Fritcher EG; Sen A; Anandasabapathy S; Bresalier RS; Marcon N; Turgeon DK; Appelman H; Normolle D; Morrison LE; Brenner DE; Halling KC
Dig Dis Sci; 2017 May; 62(5):1216-1222. PubMed ID: 28265829
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.
Brankley SM; Halling KC; Jenkins SM; Timmer MR; Iyer PG; Smyrk TC; Barr Fritcher EG; Voss JS; Kipp BR; Campion MB; Lutzke LS; Minot DM; Wang KK
Dis Esophagus; 2016 Aug; 29(6):513-9. PubMed ID: 26043762
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
[TBL] [Abstract][Full Text] [Related]
4. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.
Fritcher EG; Brankley SM; Kipp BR; Voss JS; Campion MB; Morrison LE; Legator MS; Lutzke LS; Wang KK; Sebo TJ; Halling KC
Hum Pathol; 2008 Aug; 39(8):1128-35. PubMed ID: 18602665
[TBL] [Abstract][Full Text] [Related]
5. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
6. The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus.
Brankley SM; Wang KK; Harwood AR; Miller DV; Legator MS; Lutzke LS; Kipp BR; Morrison LE; Halling KC
J Mol Diagn; 2006 May; 8(2):260-7. PubMed ID: 16645214
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus.
Evans JA; Poneros JM; Bouma BE; Bressner J; Halpern EF; Shishkov M; Lauwers GY; Mino-Kenudson M; Nishioka NS; Tearney GJ
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):38-43. PubMed ID: 16431303
[TBL] [Abstract][Full Text] [Related]
8. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
[TBL] [Abstract][Full Text] [Related]
10. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
[TBL] [Abstract][Full Text] [Related]
12. [Oncogene amplification and genetic heterogeneity in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus].
Walch A; Bink K; Hutzler P; Zitzelsberger H; Braselmann H; Aubele M; Höfler H; Werner M
Verh Dtsch Ges Pathol; 2001; 85():257-63. PubMed ID: 11894407
[TBL] [Abstract][Full Text] [Related]
13. Temporally and spectrally resolved fluorescence spectroscopy for the detection of high grade dysplasia in Barrett's esophagus.
Pfefer TJ; Paithankar DY; Poneros JM; Schomacker KT; Nishioka NS
Lasers Surg Med; 2003; 32(1):10-6. PubMed ID: 12516065
[TBL] [Abstract][Full Text] [Related]
14. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
[TBL] [Abstract][Full Text] [Related]
16. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
17. Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1.
Karamchandani DM; Lehman HL; Ohanessian SE; Massé J; Welsh PA; Odze RD; Goldblum JR; Berg AS; Stairs DB
Diagn Pathol; 2016 Feb; 11():23. PubMed ID: 26926447
[TBL] [Abstract][Full Text] [Related]
18. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.
Montgomery E; Bronner MP; Greenson JK; Haber MM; Hart J; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Goldblum JR
Am J Gastroenterol; 2002 Jan; 97(1):27-31. PubMed ID: 11808966
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and risk stratification of Barrett's dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue.
Choi WT; Tsai JH; Rabinovitch PS; Small T; Huang D; Mattis AN; Kakar S
Gut; 2018 Jul; 67(7):1229-1238. PubMed ID: 28642331
[TBL] [Abstract][Full Text] [Related]
20. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens.
Rygiel AM; Milano F; Ten Kate FJ; de Groot JG; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Genes Chromosomes Cancer; 2008 May; 47(5):396-404. PubMed ID: 18265409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
